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Aims Cyclosporine A (CsA) has represented a fundamental therapeutic weapon in immunosupression for the past three
decades. However, its clinical use is not devoid of side effects, among which hypertension and vascular injury rep-
resent a major drawback. Endothelial cells are able to generate reactive oxygen and nitrogen species upon exposure
to CsA, including formation of peroxynitrite. This may result in endothelial cell toxicity and increased tyrosine
nitration. We have now studied the subcellular origin of superoxide formation in endothelial cells treated with
CsA and the biochemical consequences for the function of mitochondrial enzymes.
Methods
and results
By using electron spin resonance and endothelial cells lacking functional mitochondria, we showed that superoxide
anion is generated in mitochondria. This was associated with an effect of CsA on bioenergetic parameters: increased
mitochondrial membrane potential and inhibition of cellular respiration. In addition, CsA inhibited the activity of the
mitochondrial enzymes aconitase and manganese superoxide dismutase (MnSOD). The use of murine lung endothelial
cells deficient in endothelial nitric oxide synthase (eNOS) and NOS/peroxynitrite inhibitors allowed us to establish that
the presence of eNOS and concomitant NO synthesis and peroxynitrite formation were essential for CsA induced
nitration and inhibition of MnSOD activity. As the latter has been shown to become inactivated by nitration, we
sought to identify this modification by mass spectrometry analysis. We found that CsA induced specific MnSOD tyro-
sine 34 nitration both in the recombinant protein and in endothelial cells overexpressing MnSOD.
Conclusion We propose that CsA induced endothelial damage may be related to increased mitochondrial superoxide formation
and subsequent peroxynitrite-dependent nitroxidative damage, specifically targeting MnSOD. The inactivation of this
key antioxidant enzyme by tyrosine nitration represents a pathophysiological cellular mechanism contributing to self-
perpetuation and amplification of CsA-related vascular toxicity.
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1. Introduction
Cyclosporine A (CsA) has been for many years an essential thera-
peutic tool in the fields of solid organ transplantation and
autoimmune diseases. Its mechanism of action, based on the inhibition
of the phosphatase calcineurin upon CsA binding to cyclophilin pro-
teins, is now well known and shared in part by other immunosuppres-
sors such as Tacrolimus.1,2 However, serious side effects associated to
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its clinical use still promote significant morbidity and dictate changes
in therapeutic strategies. Among them, vascular injury is an important
one as it is reflected in post-transplant hypertension, accelerated
atherosclerosis, and occasionally in the appearance of thrombotic
microangiopathy.3 Several reports point to the importance of oxi-
dative stress as a pathogenetic mechanism responsible for this unde-
sired damage (see4 for review). Oxidative stress is the result of the
action of reactive oxygen species (ROS)5 on different molecular
targets and it is now accepted that the latter do not only participate
in pathophysiological responses but are also important signals for
some homeostatic cellular functions.6 In addition, reactive nitrogen
species (RNS) such as nitric oxide or peroxynitrite may have a dual
physiological and pathophysiological role, and hence the term nitrox-
idative stress has been coined.7,8 Vascular injury associated to the
clinical use of CsA is pathogenetically related to endothelial dysfunc-
tion9 promoted by increased nitroxidative stress.10–13 Cellular
sources generating ROS and RNS in endothelial cells are multiple,
including several enzymatic systems and the mitochondrial electron
transport chain. The contribution of mitochondria to ROS generation
has received increasing attention in recent years and this is especially
noticeable in endothelial cells and vascular pathophysiology.14
In previous work from our laboratory, we found that CsA pro-
motes the generation of superoxide and peroxynitrite in the vascular
endothelium and that this effect is associated with increased protein
tyrosine nitration which may be prevented by the concomitant use
of antioxidant agents.15 Among these proteins, manganese superoxide
dismutase (MnSOD) appeared as a strong candidate, given the
fact that tyrosine nitration specifically inactivates its catalytic
activity16– 18 by a Mn-catalyzed nitration of tyrosine 34 (Tyr34).19
Nevertheless, several important questions remain to be answered
including: (i) the subcellular topology of ROS generation mediated
by CsA, (ii) the functional consequences of CsA treatment on the
activity of MnSOD in endothelial cells, and (iii) the identification of
specific tyrosine residues which undergo nitration induced by CsA.
In this manuscript, we provide data demonstrating the mitochondrial
generation of CsA induced superoxide in vascular endothelial cells,
the inhibition of MnSOD activity by CsA and the specific nitration
of Tyr34 promoted by CsA in this same enzyme.
2. Methods
An expanded version of Material and Methods can be found as Sup-
plementary material online.
2.1 Cells
Bovine aortic endothelial cells (BAEC) were obtained from aortas
donated by a local slaughterhouse and cultured as described.20 Mouse
lung endothelial cells (MLEC) were isolated as described.21 All protocols
used conform to the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH publication No.
85-23).
2.2 Flow cytometry
An EPICS XL analyser was used to quantitate fluorescence at the single-
cell level. Data are expressed as percentage of signal related to the
control.
2.3 MitoSOX-Red fluorescence and confocal
microscopy
Images were collected with a Leica TCS SP2 AOBS confocal microscope
(Mannheim, Germany).
2.4 Electron spin resonance experiments
Electron spin resonance (ESR) signals were detected with a Miniscope MS
200 Magnetech GmbH.
2.5 O2 consumption
Mitochondrial oxygen consumption was measured at 378C using a Clark-
type oxygen electrode (Hansatech Instruments, King’s Lynn, England).
2.6 Aconitase activity
Aconitase activity in the mitochondrial and cytosolic fractions was deter-
mined spectrophotometrically using the coupled assay with porcine heart
isocitrate dehydrogenase, as described.22
2.7 MnSOD activity
MnSOD activity was determined in cellular lysates by measuring the inhi-
bition of superoxide-dependent cytochrome c reduction generated by
xanthine oxidase/xanthine in the presence of 3 mM potassium cyanide.23
2.8 Western blot analysis
Western blot analysis was performed as described.15
2.9 MnSOD nitration
For recombinant human MnSOD nitration experiments, the protein was
incubated with conditioned media from BAEC treated with CsA
(10 mM, 2 h), its vehicle or nitrating buffer18 and then processed as
described.15
2.10 Mass spectrometry
MS analysis of peptides was performed by using a Surveyor high perform-
ance liquid chromatography (HPLC) system coupled to an LTQ linear ion
trap mass spectrometer (ThermoScientific, San Jose, CA, USA) as
described.24
2.11 Nitric oxide determination
†NO release was monitorized using an †NO electrode (ISO-NOP; World
Precision Instruments, Stevenage, Herts, UK).
2.12 Statistics
Unless otherwise specified, data are expressed as means+ SEM with the
number (n) of experiments indicated. Statistical analysis was performed by
unpaired Student’s t-test, or non-parametric tests as appropriate.
3. Results
3.1 Detection of mitochondrial-derived
superoxide radical in endothelial cells
exposed to CsA
ESR is considered a highly specific method for the detection of super-
oxide. Reaction of superoxide and hydoxyl radicals with the spin trap
5,5 dimethyl-1-pyrroline N-oxide (DMPO) yield the DMPO-OOH
adduct (t1/2, 1 min) that rapidly decays in the cellular medium to
the more stable adduct DMPO-OH. As shown in Figure 1A, when
BAEC were incubated with CsA (10 mM, 2 h), an ESR signal with
the characteristic spectral properties of DMPO-OH adduct was
observed (1:2:2:1 pattern and aN ¼ aH ¼ 14.9 G), and the signal was
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significantly abrogated in the presence of the superoxide scavenger
Tiron (1 mM),25 strongly suggesting that superoxide radical is being
formed after exposure of BAEC to CsA. The NADPH oxidase inhibi-
tor, apocynin, was unable to quench the CsA induced ESR signal
(Figure 1A). An identical signal was obtained when BAEC were
incubated with the redox cycling agent 2,3-dimethoxy-1,4-naphtho-
quinone (DMNQ) (25 mM), a known intracellular superoxide
generator (see Supplementary material online, Figure S1).
The fluorescent probe MitoSOX Red26 was used in order to investi-
gate if mitochondria are the source of CsA-dependent superoxide
production. As shown in Figure 1B, treatment of BAEC with both CsA
(10 mM, 2 h) and DMNQ (25 mM, 1 h) results in a significant increment
of cellular fluorescence, compatible with a mitochondrial localization
(see Supplementary material online, Figure S2), suggesting that an
increase in superoxide and other mitochondrial-derived oxidants are
being formed after treatment with CsA. Pre-incubation of cells with
the general antioxidant N-acetylcysteine (3 mM) markedly reduced
the CsA-dependent MitoSOX-Red fluorescent signal. In order to
confirm the important contribution of mitochondrial sources to super-
oxide generation in endothelial cells, we studied the effect of CsA on
BAEC which have been deprived of functional mitochondria (rho0).
As shown in Figure 1C, when cells were incubated with dihydroethidine
Figure 1 Cyclosporine A generates superoxide anion through mitochondria. (A) BAEC were treated with CsA (10 mM, 2 h), Tiron (1 mM, 30 min
pre-incubation), apocynin (100 mM, 30 min pre-incubation), or combinations as indicated and ESR detection of superoxide anion was performed as
described in Methods section. The ESR ‘signature’ 1:2:2:1 is depicted. A representative experiment from n ¼ 4 is shown. (B) BAEC were treated with
CsA, 2,3-dimethoxy-1,4-naphthoquinone (25 mM 1 h), NAC (3 mM, 30 min pre-incubation), or combinations as indicated and mitochondrial gener-
ation of superoxide was detected with MitoSOX fluorescent probe (red); nuclear staining by DAPI is shown in blue. A representative experiment from
n ¼ 3 is shown. (C) Native or mitochondrial-deficient (rho0) BAEC were exposed to CsA, apocynin, or combinations as indicated. Superoxide pro-
duction was evaluated by DHE fluorescence as described in Methods section. (n ¼ 7, #P, 0.05 vs. control).
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(DHE) as the fluorescent probe, a significant increase in oxidized DHE
fluorescence was detected only in native BAEC and not in rho0 cells
upon exposure to CsA, whereas apocynin failed to have any significant
effect in both cell types. BAEC treated with DMNQ followed a similar
behaviour as those exposed to CsA (see Supplementary material online,
Figure S3). We take this set of results as strongly supporting that treat-
ment of endothelial cells with CsA increases mitochondrial-derived
superoxide and/or oxidant production.
3.2 Mitochondrial bioenergetic profile
of BAEC treated with CsA
The relationship between cell respiration rate, mitochondria mem-
brane potential (DCm), and ROS production is a complex one. In
general, it is accepted that when mitochondria are respiring in state
3, there is a limited generation of superoxide anion. However,
when ADP has been phosphorylated and DCm is high, respiratory
rates are low and there is an increased superoxide generation by com-
plexes I and III.27 We sought to study the influence of CsA on several
bioenergetic parameters in BAEC. As shown in Figure 2A, CsA caused
a significant increase in DCm (measured as the fluorescence intensity
of the DiOC6 f3g probe) that was associated with a decrease in the
respiration rate (Figure 2B), a slight reduction in intracellular ATP
levels (21+ 10% compared with control) and an increase in the pro-
duction of superoxide as detected with the fluorescent probe DHE
(Figure 2C). As expected, the protonophore carbonyl cyanide-p-tri-
fluoromethoxyphenyhydrazone (FCCP) lowered DCm, stimulated
respiration (Figure 2A and B) and lowered the mitochondrial pro-
duction of superoxide (see Supplementary material online, Figure
S4A and B). In an effort to identify the relative contribution of
complex I or complex III to CsA-associated superoxide production,
we performed experiments in the presence of specific electron trans-
port inhibitors for these two complexes. The addition of different res-
piratory chain inhibitors (rotenone, myxothiazol, or antimycin A) lead
to an increase in superoxide production. The addition of CsA resulted
in a further increment in superoxide levels when rotenone or antimy-
cin A were present but not when combined with myxothiazol
(Figure 2C–E). In order to exclude a direct effect of CsA on
complex III, we determined its activity in the presence and absence
of CsA and we found no significant differences (data not shown).
3.3 Functional significance of CsA induced
ROS and RNS generation: inhibition of
mitochondrial-related enzymatic activities
Previous reported work from our laboratory showed that CsA pro-
motes the generation of peroxynitrite in endothelial cells by favouring
spatio-temporal conditions of interaction between superoxide and
†NO12,28 to yield the strong oxidant peroxynitrite. Intracellular per-
oxynitrite formation has consequences for endothelial viability, in
general promoting oxidation and nitration of cellular targets. Inhi-
bition of aconitase activity (an enzyme present in both mitochondrial
and cytosolic compartment) has been widely used as a sensitivity
assay for measuring superoxide cellular-compartment levels.22,29
Other species such as peroxynitrite or carbonate radical are able to
react with and inactivate aconitase, but their production is also a con-
sequence of an increase in superoxide steady-state level. In addition,
the mitochondrial enzyme MnSOD becomes inactivated upon
nitration. Taking into account these considerations, we were now
interested in identifying the functional relevance of CsA treatment
on the activities of these mitochondrial enzymes. Figure 3A shows
that both the mitochondrial superoxide generator DMNQ and CsA
significantly reduced mitochondrial aconitase and MnSOD activities
after short-term exposure to CsA. The effect on MnSOD activity
was also documented after 24 h of CsA treatment (Figure 3B). The
antioxidant Tiron and the tyrosine nitration inhibitor uric acid30 inhib-
ited or partially prevented the effect of CsA on MnSOD activity,
(Figure 3C and D, respectively). A similar preventive effect of Tiron
was observed on aconitase activity (n ¼ 2 by duplicate, data not
shown). Aconitase activity was also reduced in cytosolic fractions
(data not shown) even when no significant contamination of mito-
chondria in the cytosolic fractions was detected, as determined by
western blot against MnSOD (see Supplementary material online,
Figure S5).
To prove that the nitration induced by CsA was NOS dependent
and that NOS inhibition prevented CsA induced enzymatic inacti-
vation, we performed two types of experiments. First, we studied
tyrosine nitration in MLEC arising from both wild-type and endothelial
nitric oxide synthase (eNOS) deficient animals. CsA induced tyrosine
nitration only in wild-type MLEC as opposed to the peroxynitrite
exogenous generator SIN-1 (1,3-morpholino sydnonimine), which
also had an effect in MLEC from eNOS-deficient animals
(Figure 4A). The nitration pattern correlated well with the levels of
nitrite (NO2
2) in the extracellular medium, as it was determined
using a selective NO electrode (Figure 4B). In addition, the NOS
inhibitor 2-amino-4-methylpyridine significantly abrogated the effect
of CsA on MnSOD activity (Figure 4C). These data imply that the gen-
eration of superoxide and peroxynitrite by CsA has important func-
tional consequences for the activities of mitochondrial aconitase
and MnSOD, both enzymes with a mitochondrial localization. In
addition, CsA induced an increase in peroxynitrite generation (as
determined by DHR123 flow cytometry experiments) which was
only present in wild-type MLEC (Figure 4D).
3.4 Identification of Tyr34 as the nitrated
residue of MnSOD in endothelial cells
treated with CsA
Tyr34 has been identified as a critical target for the in vitro nitration
and inactivation of MnSOD with functional consequences also
in vivo.31,32 Thus, it was important to find out if treatment of endo-
thelial cells with CsA could specifically affect this residue. We first
set up the conditions for characterizing Tyr34 nitration by mass spec-
trometry in a preparation of rHuMnSOD exposed to a nitrating
buffer.18 This was accomplished by selected MS/MS ion monitoring
(SMIM) using a HPLC-linear ion trap mass spectrometer.24,33,34 The
detector was programmed to perform multiple fragmentations of
the ions corresponding to the non-modified and Tyr-nitrated forms
of the tryptic peptide HHAAY34VNNLNVTEEK from MnSOD. By
monitoring the fragmentation of the precursor ions and the subfrag-
mentation of one of the most intense fragments, we could demon-
strate the nitration at Tyr34 (data not shown). Once the conditions
for specifically detecting Tyr34 nitration by SMIM were optimized,
we applied the technique to the analysis of rHuMnSOD incubated
in the presence of conditioned medium of cells exposed to CsA.
The fragmentation patterns and the presence of specific fragments
for the non-modified and nitro-Tyr forms of the peptide demon-
strated that incubation of the recombinant protein with the con-
ditioned medium produced nitration at the Tyr34 residue of
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Figure 2 Cyclosporine A modifies the mitochondrial bioenergetic profile consistently with increased superoxide production. (A) Effect of CsA on
membrane potential as determined with the DiOC6 f3g probe. BAEC were treated with CsA or the protonophore FCCP as a control which induces
membrane uncoupling (n ¼ 4, #P, 0.05 vs. control). (B) Effect of CsA on the oxygen consumption of BAEC. Left panel: representative oxygen elec-
trode traces of the effect of CsA 10 mM, oligomycin (O, 2 mg/mL) or its vehicle (V) and the uncoupler FCCP (F; 10 mM). It represents the respiratory
rates expressed as nmol ‘O’ min21 106 cells21. Right panel: histogram with the summary of the effects of the agents on BAEC respiration (n ¼ 4,
#P, 0.05 vs. basal or CsA vehicle). (C–E) Effect of complex I and III inhibitors on CsA induced superoxide generation. BAEC were pre-treated
with the complex I inhibitor Rotenone (4 mM, 30 min) or the complex III inhibitors myxothiazol (10 mM, 30 min) or antimycin (2 mM, 30 min)
and then treated with CsA (10 mM, 2 h) as described in Methods section. Superoxide production was evaluated by DHE fluorescence. (C)
n ¼ 10, #P, 0.05 vs. control; $P, 0.05 vs. CsA. (D) n ¼ 3, #P, 0.05 vs. control; $P, 0.05 vs. CsA. (E) n ¼ 4, #P, 0.05 vs. control.
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MnSOD (see Supplementary material online, Figure S6). Finally, the
same approach was followed to analyse this modification in endo-
thelial cells treated with CsA. For this purpose, whole protein extracts
from BAEC infected with adenoviral constructs bearing MnSOD were
used to perform the same analysis. These infections did not modify
the capacity of CsA to induce protein nitration (see Supplementary
material online, Figure S7). As shown in Figure 5B, the chromatogram
trace of specific fragment ions revealed that the modified peptide was
present at a negligible proportion in the extracts from vehicle-treated
cells. In clear contrast, when the cells were treated with CsA, the
intensity of the non-modified peptide decreased (Figure 5A),
whereas that of the modified peptide increased (Figure 5B). The MS/
MS and MS3 fragment spectra obtained at the elution times of these
peaks demonstrated unequivocally the sequence of the peptide and
the presence of a modification by 45 Da in Tyr34 (Figure 5C and D),
consistent with Tyr-nitration at this site. Altogether, these data
provide strong evidence suggesting that CsA is able to promote
MnSOD nitration in endothelial cells precisely at the residue which
is essential for a correct catalytic activation of the enzyme, hence
identifying a specific biochemical target for CsA induced endothelial
toxicity.
4. Discussion
This study provides molecular insight into the mechanism of endo-
thelial toxicity associated to CsA. Data presented here strongly
support that superoxide production is mainly of mitochondrial
origin and that CsA causes a change in membrane potential that
leads to a decrease in the respiratory rate and increased ROS gener-
ation. This results in a functional inactivation of the mitochondrial
enzymes aconitase and MnSOD. Finally, tyrosine nitration of
MnSOD by CsA is assigned to a specific residue (Tyr34) which is
essential for its catalytic function on superoxide elimination.
The association between CsA treatment and increased oxidative
stress has been accepted for several years based not only on exper-
imental data but also on clinical observations. In fact, CsA induced
Figure 3 Cyclosporine A causes functional inactivation of Mn-superoxide dismutase and aconitase. (A) BAEC were treated with CsA (10 mM, 2 h)
or DMNQ (25 mM, 1 h) and mitochondrial aconitase and MnSOD activities were determined as described in Methods section (n ¼ 4 for each enzyme,
#P, 0.05 vs. control; $P, 0.05 vs. control). (B) BAEC were exposed to CsA (1 mM, 24 h), and MnSOD activity was determined (n ¼ 3, *P, 0.05).
(C) Effect of Tiron on the prevention of CsA-associated inhibition of MnSOD activity. BAEC were exposed to Tiron (1 mM, 30 min pre-incubation),
and then treated as described in (A) (n ¼ 3, #P, 0.05 vs. control). (D) Effect of uric acid (160 mM) on the prevention of CsA-associated inhibition of
MnSOD activity. BAEC were treated with CsA (10 mM, 2 h) alone or in the presence of uric acid (160 mM), and then MnSOD activity was determined
as described in Methods section (n ¼ 3, #P, 0.05 vs. control, $P, 0.05 vs. treatment with CsA).
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hypertension is related to increased ROS production.35 We and
others have provided evidence for the presence of nitroxidative
stress in cells from the vascular wall.5,15,36 Data herein presented
demonstrate unequivocally by using ESR and fluorescent probes
that endothelial cells generate ROS under exposure to CsA. Although
it is possible that hydroxyl radical could account for the characteristic
ESR signal, abrogation by Tiron and overwhelming evidence on the
production of superoxide by mitochondria make this scenario unli-
kely. Few studies have addressed the issue of the source of ROS in
endothelial cells. This work clearly shows that endothelial mitochon-
dria are potential generators of superoxide anion in the presence of
CsA (Figure 1B). The general nicotinamide adenine dinucleotide phos-
phate oxidase inhibitor, apocynin, did not result in an inhibition of
superoxide production, thus excluding NADPH oxidase as a funda-
mental source of CsA induced oxidative stress in BAEC. However,
the fact that cytosolic aconitase is also partially inhibited by CsA
does not completely exclude the possibility of other superoxide
sources aside from mitochondria. Besides, results obtained in cells
with the absence of functional mitochondria revealed that these orga-
nelles are critical for CsA-associated production of superoxide.
However, other authors have found that other endothelial cell
types may behave differently in response to CsA.37 In addition, uncou-
pling of eNOS has also been suggested as a mechanism for
CsA induced superoxide generation in animal models.38 In our
study, the presence of eNOS was clearly necessary for the generation
of peroxynitrite and induction of nitration (Figure 4), thus suggesting
that this mechanism could also be contributing to superoxide
generation.
The effects of CsA on mitochondrial function need to be inter-
preted in the context of established actions of this drug on the mito-
chondrial permeability transition pore (PTP). Among CsA direct
actions, binding to cyclophilin D in the mitochondrial matrix leads
to the inhibition of the PTP. PTP opens under a variety of conditions
related to mitochondrial dysfunction like ROS-induced damage, an
elevation of mitochondrial calcium and phosphate, depletion of pyri-
dine nucleotides, or high levels of fatty acids. Prolonged PTP
opening leads to matrix swelling and disruption of the outer mem-
brane with the concomitant release of pro-apoptotic factors. The
inhibition of PTP opening by CsA can be used to increase the cell via-
bility and prevent, for example, cell death after ischaemia–
Figure 4 The eNOS pathway is necessary for CsA-dependent nitration and peroxynitrite formation. (A) MLEC wild-type and knockout (KO) for
eNOS were exposed to CsA (10 mM, 2 h) or the generator of peroxynitrite SIN-1 (100 mM, 2 h), and protein lysates were processed as described in
Methods section. Control cellular extracts were exogenously treated with the same concentration of SIN-1 for 1 h (extr/SIN-1). Tyrosine nitration
was evaluated by immunoblot. (B) NO2
2 accumulation was determined with a selective NO electrode in supernatants of MLEC exposed to CsA or
SIN-1, in the conditions described above (n ¼ 3, #P, 0.05 vs. control). (C) BAEC were treated with CsA (10 mM, 2 h) alone or in the presence of
AMPy (100 mM), and then MnSOD activity was determined as described in Methods section (n ¼ 3, #P, 0.05 vs. control). (D) Peroxynitrite for-
mation in MLEC (wild-type or KO) was evaluated by flow cytometry using DHR123 fluorescence (n ¼ 3, #P, 0.05 vs. control).
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Figure 5 Cyclosporine A induces nitration of Tyr34 in MnSOD. Identification of the MnSOD peptide HHAAYVNNLNVTEEK nitrated at Tyr34 (A,
B) MS/MS (upper panels) and MS3 (lower panels) traces from selected peptide fragments corresponding to the non-nitrated (A) and the nitrated
peptide (B) from protein extracts from BAEC infected with adenoviral constructs bearing human MnSOD and treated with either vehicle
(control) or CsA. The upper panels correspond to the trace of fragment y6
þ and the lower panels to the trace of subfragment b9
*2þ originated
from fragment b9
2þ. (C and D) MS/MS and MS3 spectra of the peptide species at the elution times of peaks detected in (B). The MS3 spectrum in
(D) was obtained from the doubly charged ion b9
2þ detected in (C). Fragments corresponding to the loss of internal amino acids from b ions are
indicated with the same nomenclature used previously.53 Note that fragments of this kind are observed with some frequency upon refragmentation
and their formation is thought to arise from cyclation of intense b ions.53 Spectra correspond to a representative experiment repeated twice.
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reperfusion.39 However, electrophysiological studies have shown that
the PTP can also open transiently (in the millisecond range) and this
channel activity is referred to as ‘conductance flickerings’.40 These
transient openings are also CsA sensitive and probably related to fluc-
tuations in physiological parameters such as matrix pH or to physio-
logical activities like protein import or fast calcium release. The
flickering of the PTP is therefore a physiological event that does not
necessarily lead to the dramatic effects due to the permanent
opening of the PTP.41 We have observed a CsA induced increase in
DCm that could be due to the inhibition of the flickering of the
pore (Figure 2A). The observed decrease in respiration (Figure 2B)
would also be a consequence of the increased efficiency of the oxi-
dative phosphorylation and higher DCm.
The effect of the two modes of PTP opening would have different
consequences on the mitochondrial production of superoxide. It has
been reported that prolonged opening of the PTP is associated with
increased levels of H2O2 in mitochondria due to a specific confor-
mational change in complex I.42 The loss of cytochrome c, due to
the rupture of the outer mitochondrial membrane, has also been con-
sidered a cause of both the inhibition of respiration and the concomi-
tant increase in ROS production due to the opening of the PTP.43,44
However, recent studies in cardiomyocytes subjected to ischaemia–
reperfusion have shown that the production of ROS increase when
the PTP is inhibited by CsA,45 in keeping with data presented here.
We believe that the marked increase in DHE fluorescence that we
have observed in the presence of CsA is consistent with a possible
non-permanent inhibition of the PTP.
MnSOD (SOD-2) is a mitochondrial enzyme considered to be
essential as a first-line superoxide detoxifier. In the vascular wall,
this enzyme has been shown to play a crucial role in vascular protec-
tion.46 MnSOD converts superoxide into hydrogen peroxide plus
molecular oxygen. This conversion has several purposes including
the protection of †NO and mitochondrial proteins such as aconitase
or fumarase from inactivation by superoxide.46 The Mn atom is essen-
tial for redox cycling and the Tyr34 residue lies in close proximity to
this atom and hence to the active site.47 Nitration of this residue was
demonstrated more than 10 years ago and it is widely accepted that
this modification involves enzymatic inactivation.8 Moreover, peroxy-
nitrite is the only known biological oxidant competent to inactivate
MnSOD enzymatic activity.47 Several studies have highlighted the
pathophysiological importance of MnSOD nitration in a panoply of
disease models, including chronic renal allograft rejection,16 traumatic
brain injury,48 ageing,49 and angiotensin II-induced hypertension.50 We
now provide evidence for the functional inactivation of MnSOD by
CsA together with a repercussion on the function of an exquisitely
sensitive enzyme to superoxide, aconitase (Figure 3). Also, and for
the first time to our knowledge, we show that CsA induced nitration
of MnSOD takes place precisely at Tyr34, thus offering a biochemical
explanation for MnSOD inactivation (Figure 5). Furthermore, the pro-
tection from MnSOD inactivation by treatment of the cells with uric
acid, a well known anti-nitrating compound via scavenging of
peroxynitrite-derived radicals,51,52 further supports a direct link
between CsA toxicity and mitochondrial nitroxidative stress.
Although we attempted to quantitate the amount of nitration of
MnSOD, experiments using an antibody specifically directed against
nitrated MnSOD (nY-34)49 were inconclusive (data not shown).
Nitration of Tyr34 in MnSOD can lead to a fully inactivated
enzyme;19 the fact that we only observed about 40% inhibition of
MnSOD in the presence of CsA supports that only a fraction of the
total MnSOD pool becomes nitrated in the critical tyrosine upon
CsA exposure. Indeed, fractional MnSOD nitration/inactivation
under cellular conditions will depend on both the overall production
of peroxynitrite over the incubation period and the competing reac-
tions with other targets and detoxification systems. Given these con-
siderations, one can conclude that peroxynitrite formation in the
system under study was large, as it significantly dropped the activity
of MnSOD, typically present at 10–20 mM concentrations in mito-
chondria.29 In addition, experiments performed in BAEC infected
with adenoviral constructs bearing a MnSOD expression plasmid
strongly suggest that CsA induced Tyr34 nitration is operative in
endothelial cells. Of interest, the concentrations of CsA used in this
study (1–10 mM) are slightly above the high limit of the therapeutic
range of concentrations found in renal transplant patients treated
with these agents, and hence expected to be found in the context
of vascular toxicity. Thus, it is tempting to speculate that a reduced
catalytic activity of endothelial MnSOD would contribute to amplify
nitroxidative stress and to promote the self-perpetuation of endo-
thelial damage.
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